BackCore Scientific- Warrants Tranche 2 (23/01/2029) Overview

Core Scientific- Warrants Tranche 2 (23/01/2029) Profit Margin

Core Scientific- Warrants Tranche 2 (23/01/2029) (CORZZ) has a profit margin of -325.91%, below the Technology sector average of 71.24%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-703.59%
↑ 40.95% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-325.91%
↓ 5.45% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Core Scientific- Warrants Tranche 2 (23/01/2029) (CORZZ) FAQ

Core Scientific- Warrants Tranche 2 (23/01/2029) posts a profit margin of -325.91% as of June 2026. That compares with -309.07% in the prior-year period — down 5.4% year over year. That is below the Technology sector average of 71.24%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Core Scientific- Warrants Tranche 2 (23/01/2029)'s profit margin was -309.07%. The latest reading is -325.91% — a 5.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Technology stocks, a profit margin near 71.24% is typical. Core Scientific- Warrants Tranche 2 (23/01/2029)'s -325.91% is lower that level. That is roughly 557.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Core Scientific- Warrants Tranche 2 (23/01/2029)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -325.91% as of June 2026; use YoY and peer views to separate noise from signal.

Context for CORZZ's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 71.24%), and (3) consistency with growth and profitability. This page covers the first two; Core Scientific- Warrants Tranche 2 (23/01/2029)'s other metric pages and overview cover the third.